Literature DB >> 25471139

Moving toward a novel and comprehensive behavioral composite of engagement in HIV care.

Parya Saberi1, Mallory O Johnson.   

Abstract

Suboptimal engagement in HIV care increases the risk of HIV-related morbidity and mortality; however, a comprehensive and practical measure of engagement in care does not exist. The objective of our study was to identify and develop a composite of engagement in HIV care. From May to August 2013, we conducted a cross-sectional study of HIV-positive individuals who consented to participate in an online survey. Engagement in care was assessed by the following self-reported variables: (1) having attended an HIV health-care provider appointment in the past six months, (2) reporting a scheduled future HIV health-care provider appointment, (3) knowing their last CD4(+) cell count, (4) knowing their antiretroviral (ARV) medication names, (5) reporting ARV adherence ≥80% on the visual analog scale (VAS) and rating scale, (6) reporting adherence ≥90% on the VAS and rating scale, and (7) not having missed all ARVs for at least four days in a row in the past three months. To create the composite of engagement in care, the presence or absence of these variables were summed and categorized (7 = "high engagement," 5-6 = "moderate engagement," and 0-4 = "low engagement"). We examined the correlation between this composite and self-reported HIV viral load (VL; detectable versus undetectable) in a logistic regression model. We surveyed 1259 HIV-positive individuals: 85% reporting an undetectable VL and 67% reporting excellent adherence. Approximately 89%, 88%, and 67% of those with high, moderate, and low engagement, respectively, had an undetectable VL. Having moderate engagement was associated with 3.5-fold higher odds, and high engagement was associated with 4.0-fold higher odds of virologic undetectability compared to low engagement (overall p-value < 0.0001). Our data indicate that this novel and comprehensive composite of engagement may be a useful tool in clinical and research settings given its high correlation with virologic outcomes. Future research should validate this composite in other populations and examine it prospectively.

Entities:  

Keywords:  HIV; adherence; continuum of care; engagement in care; retention in care

Mesh:

Substances:

Year:  2014        PMID: 25471139      PMCID: PMC4336586          DOI: 10.1080/09540121.2014.986052

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  19 in total

1.  Nonadherence to medical appointments is associated with increased plasma HIV RNA and decreased CD4 cell counts in a community-based HIV primary care clinic.

Authors:  M B Berg; S A Safren; M J Mimiaga; C Grasso; S Boswell; K H Mayer
Journal:  AIDS Care       Date:  2005-10

2.  Optimal recall period and response task for self-reported HIV medication adherence.

Authors:  Minyi Lu; Steven A Safren; Paul R Skolnik; William H Rogers; William Coady; Helene Hardy; Ira B Wilson
Journal:  AIDS Behav       Date:  2007-06-19

3.  Association of medical insurance and other factors with receipt of antiretroviral therapy.

Authors:  Jeanne C Keruly; Richard Conviser; Richard D Moore
Journal:  Am J Public Health       Date:  2002-05       Impact factor: 9.308

Review 4.  The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection.

Authors:  Edward M Gardner; Margaret P McLees; John F Steiner; Carlos Del Rio; William J Burman
Journal:  Clin Infect Dis       Date:  2011-03-15       Impact factor: 9.079

5.  Measuring retention in HIV care: the elusive gold standard.

Authors:  Michael J Mugavero; Andrew O Westfall; Anne Zinski; Jessica Davila; Mari-Lynn Drainoni; Lytt I Gardner; Jeanne C Keruly; Faye Malitz; Gary Marks; Lisa Metsch; Tracey E Wilson; Thomas P Giordano
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-15       Impact factor: 3.731

Review 6.  From access to engagement: measuring retention in outpatient HIV clinical care.

Authors:  Michael J Mugavero; Jessica A Davila; Christa R Nevin; Thomas P Giordano
Journal:  AIDS Patient Care STDS       Date:  2010-10       Impact factor: 5.078

7.  Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions.

Authors:  G M Lucas; R E Chaisson; R D Moore
Journal:  Ann Intern Med       Date:  1999-07-20       Impact factor: 25.391

8.  Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting.

Authors:  Jessica H Oyugi; Jayne Byakika-Tusiime; Edwin D Charlebois; Cissy Kityo; Roy Mugerwa; Peter Mugyenyi; David R Bangsberg
Journal:  J Acquir Immune Defic Syndr       Date:  2004-08-15       Impact factor: 3.731

9.  The therapeutic implications of timely linkage and early retention in HIV care.

Authors:  Kimberly B Ulett; James H Willig; Hui-Yi Lin; Justin S Routman; Sarah Abroms; Jeroan Allison; Ashlee Chatham; James L Raper; Michael S Saag; Michael J Mugavero
Journal:  AIDS Patient Care STDS       Date:  2009-01       Impact factor: 5.078

10.  Estimating the regional distribution of men who have sex with men (MSM) based on Internet surveys.

Authors:  Ulrich Marcus; Axel J Schmidt; Osamah Hamouda; Michael Bochow
Journal:  BMC Public Health       Date:  2009-06-11       Impact factor: 3.295

View more
  6 in total

1.  HIV Disclosure and Transmission Risks to Sex Partners Among HIV-Positive Men.

Authors:  Seth C Kalichman; Moira O Kalichman; Chauncey Cherry; Tamar Grebler
Journal:  AIDS Patient Care STDS       Date:  2016-05       Impact factor: 5.078

2.  Study protocol: a pilot randomised waitlist-controlled trial of a dyadic mobile health intervention for black sexual-minority male couples with HIV in the USA.

Authors:  Hyunjin Cindy Kim; Lance M Pollack; Parya Saberi; Torsten B Neilands; Emily A Arnold; Darius Jovon Bright; Robert W Williams; Susan M Kegeles; Judy Y Tan
Journal:  BMJ Open       Date:  2021-09-02       Impact factor: 3.006

3.  Accuracy of self-report of HIV viral load among people with HIV on antiretroviral treatment.

Authors:  J Sewell; M Daskalopoulou; F Nakagawa; F C Lampe; S Edwards; N Perry; E Wilkins; R O'Connell; M Jones; S Collins; A Speakman; A N Phillips; A J Rodger
Journal:  HIV Med       Date:  2016-12-22       Impact factor: 3.180

4.  Randomized Controlled Trial of Healthy Divas: A Gender-Affirming, Peer-Delivered Intervention to Improve HIV Care Engagement Among Transgender Women Living With HIV.

Authors:  Jae M Sevelius; Samantha E Dilworth; Cathy J Reback; Deepalika Chakravarty; Danielle Castro; Mallory O Johnson; Breonna McCree; Akira Jackson; Raymond P Mata; Torsten B Neilands
Journal:  J Acquir Immune Defic Syndr       Date:  2022-03-05       Impact factor: 3.771

5.  Patient-Identified Markers of Quality Care: Improving HIV Service Delivery for Older African Americans.

Authors:  Brandon D Mitchell; Liz Utterback; Paul Hibbeler; Ashley R Logsdon; Patricia F Smith; Lesley M Harris; Billie Castle; Jelani Kerr; Timothy N Crawford
Journal:  J Racial Ethn Health Disparities       Date:  2022-01-21

6.  Healthcare retention and clinical outcomes among adolescents living with HIV after transition from pediatric to adult care: a systematic review.

Authors:  Tiarney D Ritchwood; Vincenzo Malo; Cameron Jones; Isha W Metzger; Millicent Atujuna; Rebecca Marcus; Donaldson F Conserve; Lara Handler; Linda-Gail Bekker
Journal:  BMC Public Health       Date:  2020-08-03       Impact factor: 4.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.